Compare PTGX & TDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PTGX | TDS |
|---|---|---|
| Founded | 2006 | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Telecommunications Equipment |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.1B | 5.2B |
| IPO Year | 2016 | N/A |
| Metric | PTGX | TDS |
|---|---|---|
| Price | $82.47 | $43.53 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 3 |
| Target Price | ★ $93.00 | $51.67 |
| AVG Volume (30 Days) | 788.9K | ★ 999.3K |
| Earning Date | 02-20-2026 | 02-20-2026 |
| Dividend Yield | N/A | ★ 0.37% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.72 | N/A |
| Revenue | $209,217,000.00 | ★ $4,859,865,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $409.41 | N/A |
| P/E Ratio | $115.35 | ★ N/A |
| Revenue Growth | N/A | ★ 110.05 |
| 52 Week Low | $33.70 | $31.07 |
| 52 Week High | $96.54 | $45.02 |
| Indicator | PTGX | TDS |
|---|---|---|
| Relative Strength Index (RSI) | 44.12 | 58.95 |
| Support Level | $81.94 | $42.74 |
| Resistance Level | $85.50 | $44.91 |
| Average True Range (ATR) | 3.16 | 1.30 |
| MACD | 0.02 | -0.04 |
| Stochastic Oscillator | 40.39 | 69.23 |
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
Telephone and Data Systems Inc is a diversified telecommunications operator that provides mobile, telephone, and broadband services. The company's segments include UScellular Wireless, UScellular Towers, and TDS Telecom. It generates maximum revenue from the UScellular Wireless segment.